Advertisement
Screener

NEXENTIS TECHNOLOGIES INC. (NXTS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

1.6 / 5 stars · 17/54 Roast Me

NEXENTIS TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

NEXENTIS TECHNOLOGIES INC. (NXTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 37 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2025-11-13

  • NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was -1.26K shares.
  • NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was 0.00 shares.
  • NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-03-31 was 1.29K shares.
  • NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 66.67K shares.
  • NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 33.33K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month
2025-09-30-1.26K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-1.26K shares
derived: sum of 2 quarters · filed 2025-11-13
37.00 shares
10-Q · filed 2025-11-13
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
1.29K shares
10-Q · filed 2025-08-14
2025-03-311.29K shares
10-Q · filed 2025-05-15
2020-09-3066.67K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
158.34K shares
derived: sum of 2 quarters · filed 2020-11-12
216.67K shares
10-Q · filed 2020-11-12
2020-06-3091.67K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
150.00K shares
10-Q · filed 2020-08-11
2020-03-3158.33K shares
10-Q · filed 2020-05-15
2019-12-3133.33K shares
10-K · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02